COMMUNIQUÉS West-GlobeNewswire

Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative
10/09/2026
TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Nuclear Isotope Council (CNIC) today announced Canada’s first official contribution to the International Atomic Energy Agency’s (IAEA) Rays of Hope initiative, a [...]
UPDATE -- Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
Interra Health Adds Support for New GLP-1 Bridge Program, Helping Seniors on Medicare Access Weight-Loss Medications
10/09/2026
Within just two months, the program has reached 30,000+ prescribers and delivered 170,000+ point-of-prescribe alerts, helping Medicare patients access GLP-1 medication for obesity for just $50/month BOSTON, Sept. 10, [...]
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that [...]
Vanquish Brands Partners with Select BC Craft Growers to Bring Premium Cannabis to Markets Across Canada Via the Pistol and Paris Brand
10/09/2026
AGASSIZ, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc. (“Vanquish”), operating under the Vanquish Brands name, is a Canadian cannabis house-built Legacy to Legal™, combining the standards, [...]
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today [...]
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
10/09/2026
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30% SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada [...]
Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
10/09/2026
New production framework designed to support continuous manufacturing, greater operating efficiency and long-term program visibility LITTLETON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc [...]
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
10/09/2026
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform- [...]
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
10/09/2026
SHENZHEN, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- On September 9, BGI Group held its 2026 Global New Product Launch Event at BGI Center in Shenzhen, marking the organization’s 27th anniversary. Under the theme “ [...]
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and [...]
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune [...]
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
10/09/2026
The new financing structure provides greater financial flexibility through an expanded $40 million revolving credit facility, reduced borrowing costs and an extended maturity to December 31, 2029 MONTREAL, Sept. 10, [...]
Cannara étend son financement à une facilité de crédit syndiquée de 80 millions de dollars auprès de BMO et de la Banque TD, renforçant ainsi davantage ses bases financières pour poursuivre sa croissance
10/09/2026
Cette nouvelle structure de financement offre une plus grande souplesse financière grâce à une facilité de crédit renouvelable portée à 40 millions de dollars, à une réduction des coûts d’emprunt et à une prolongation [...]
Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
10/09/2026
Oral presentation to share updated monotherapy clinical data for ERAS-0015 including additional patients and longer follow-up, expanding on the previously reported preliminary results from the ongoing AURORAS-1 Phase 1 [...]
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
10/09/2026
Second clinical-stage asset generated from the company’s proprietary library of SIRP-targeted antibodies SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, a clinical-stage [...]
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, [...]
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
10/09/2026
Updated long-term follow-up data will be presented from CARTITUDE-2 Cohort A in patients with lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy Real-world evidence and post-authorization safety [...]

Pages